ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Kiniksa Pharmaceuticals (UK), Ltd

Kiniksa Pharmaceuticals (UK), Ltd is an active company incorporated on 6 December 2018 with the registered office located in London, Greater London. Kiniksa Pharmaceuticals (UK), Ltd was registered 6 years ago.
Status
Active
Active since incorporation
Company No
11716038
Private limited company
Age
6 years
Incorporated 6 December 2018
Size
Large
Turnover is over £54M
Balance sheet is over £27M
Confirmation
Submitted
Dated 5 December 2024 (9 months ago)
Next confirmation dated 5 December 2025
Due by 19 December 2025 (3 months remaining)
Last change occurred 9 months ago
Accounts
Due Soon
For period 1 Jan31 Dec 2023 (12 months)
Accounts type is Full
Next accounts for period 31 December 2024
Due by 30 September 2025 (23 days remaining)
Contact
Address
Kiniksa Pharmaceuticals (Uk) Ltd,
Third Floor, 23 Old Bond Street
London
W1S 4PZ
United Kingdom
Address changed on 10 Mar 2022 (3 years ago)
Previous address was
Telephone
Unreported
Email
Unreported
Website
Unreported
People
Officers
5
Shareholders
1
Controllers (PSC)
1
Director • British • Lives in England • Born in May 1980
Director • British • Lives in England • Born in Jun 1981
Director • British • Lives in UK • Born in Oct 1980
Director • American • Lives in United States • Born in Apr 1974
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Kiniksa Pharmaceuticals International, Plc
Ross Michael Moat is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2019–2023)
Period Ended
31 Dec 2023
For period 31 Dec31 Dec 2023
Traded for 12 months
Cash in Bank
£54.7M
Increased by £7.53M (+16%)
Turnover
£212.92M
Increased by £30.59M (+17%)
Employees
12
Increased by 3 (+33%)
Total Assets
£773.56M
Increased by £65.17M (+9%)
Total Liabilities
-£65.93M
Increased by £9.88M (+18%)
Net Assets
£707.63M
Increased by £55.29M (+8%)
Debt Ratio (%)
9%
Increased by 0.61% (+8%)
Latest Activity
Confirmation Submitted
9 Months Ago on 9 Dec 2024
Full Accounts Submitted
11 Months Ago on 6 Oct 2024
Ross Michael Moat Resigned
1 Year 1 Month Ago on 1 Aug 2024
Kiniksa Pharmaceuticals, Ltd. (PSC) Resigned
1 Year 2 Months Ago on 27 Jun 2024
Kiniksa Pharmaceuticals International, Plc (PSC) Appointed
1 Year 2 Months Ago on 27 Jun 2024
Confirmation Submitted
1 Year 7 Months Ago on 12 Jan 2024
Full Accounts Submitted
1 Year 11 Months Ago on 12 Oct 2023
Sanjiv Patel Resigned
2 Years 6 Months Ago on 17 Feb 2023
Small Accounts Submitted
2 Years 8 Months Ago on 7 Jan 2023
Confirmation Submitted
2 Years 8 Months Ago on 5 Jan 2023
Get Credit Report
Discover Kiniksa Pharmaceuticals (UK), Ltd's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Confirmation statement made on 5 December 2024 with updates
Submitted on 9 Dec 2024
Full accounts made up to 31 December 2023
Submitted on 6 Oct 2024
Termination of appointment of Ross Michael Moat as a director on 1 August 2024
Submitted on 20 Aug 2024
Notification of Kiniksa Pharmaceuticals International, Plc as a person with significant control on 27 June 2024
Submitted on 2 Jul 2024
Cessation of Kiniksa Pharmaceuticals, Ltd. as a person with significant control on 27 June 2024
Submitted on 2 Jul 2024
Statement of capital on 17 May 2024
Submitted on 17 May 2024
Resolutions
Submitted on 17 May 2024
Solvency Statement dated 12/05/24
Submitted on 17 May 2024
Statement by Directors
Submitted on 17 May 2024
Confirmation statement made on 5 December 2023 with no updates
Submitted on 12 Jan 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year